ConvaTec raises FY outlook as YTD revenues improve
Sharecast
Published Nov 10, 2022 08:50
Updated Nov 10, 2022 09:13
ConvaTec raises FY outlook as YTD revenues improve
On a constant currency basis, revenue was up 7.8% and was up 6.3% on an organic basis. Following "sustained good sales growth", Convatec also increased its guidance for 2022 organic revenue growth to 5.4-5.8% from 4.0-5.5%.
Convatec said its advanced wound care unit had seen "high single-digit" organic revenue growth over the first ten months of the year, while ostomy care revenues were up low single digits, and continence and critical care revenues were up mid-single digits. Infusion care revenues were up double-digits for the first 10 months, slightly lower than in the first half.
For the year as a whole, Convatec said: "Inflation in raw materials and freight has moderated in recent months, but inflation in utilities and labour has increased. Overall, we continue to expect COGS inflation of 8-9% for the year and we continue to expect to deliver constant currency adjusted operating profit margin of at least 18%.
"Foreign exchange rate movements have been volatile in recent months. The FX impact on 2022 is currently estimated to be a ~6% headwind on revenue growth with a ~90bps tailwind to the EBIT margin. These estimates are based on actual rates to 31 October and spot rates for the remainder of the year. On this basis, we expect to publish an adjusted operating profit margin of over 19%."
As of 0850 GMT, Convatec shares were up 5.19% at 222.80p.
Reporting by Iain Gilbert at Sharecast.com
Read more on Sharecast.com
Get The App
Written By: Sharecast
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.